CytoSorbents Corporation announced an exclusive multi-year distribution agreement with Hoang Long Pharma, a medical distributor in Vietnam specializing in the distribution of innovative pharmaceuticals, biologics, and devices to treat patients suffering from critical illnesses, immunologic disorders and deficiencies, and infections. This multi-year agreement includes all critical care applications in Vietnam, and is subject to annual minimum purchases of CytoSorb(r) to maintain exclusivity.